Drug Trial Radar · NCT05987371
A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.
Last checked: Nov 20, 2026Latest source record: Apr 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
75
Actual
Start
Aug 23, 2023
Primary completion
Jan 16, 2024
Study completion Apr 23, 2024
Sponsor
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 30 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase II clinical trial to evaluate the efficacy and safety of TQC3721 Suspension for Inhalation in patients with moderate to severe Chronic obstructive pulmonary disease (COPD).
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
TQC3721 suspension for inhalationDrug
TQC3721 suspension for inhalation is a dual inhibitor targeting PDE3/4.
TQC3721 matching placebo for inhalationDrug
Placebo without active substance.
Salbutamol sulfate inhalation aerosolDrug
Salbutamol is short-acting β2 receptor agonists.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The peak of Forced Expiratory Volume in the 1st second (FEV1) (4 weeks)Time frame: From baseline to four weeks after treatment.
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
The Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China
Wuhan Sixth Hospital
Wuhan, Hubei, China
Changsha Third Hospital
Changsha, Hunan, China
Northern Jiangsu People's Hospital
Yangzhou, Jiangsu, China
People's Hospital of Jiangxi province
Nanchang, Jiangxi, China
The first hospital of Jilin University
Changchun, Jilin, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Mianyang Central Hospital
Mianyang, Sichuan, China
Suining Central Hospital
Suining, Sichuan, China
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.